EP1438966
Title:
Toepassing van depsipeptide en analogen daarvan als immuno-onderdrukkende middelen voor het behandelen van een infectie-ziekte , auto-immune ziekte, allergische reacties of een hyperproliferatieve huidziekte.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1438966
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP04007814.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
06/12/2000
Grant date:
14/02/2007
EP Publication Date:
14/02/2007
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/07/2010
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/02/2007
EP B1 Publication Date:
14/02/2007
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/12/2020
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
14/02/2007
Name:
Cyclacel Pharmaceuticals, Inc.
Address:
200 Connell Drive, 07922, Berkeley Heights, New Jersey, United States of America (US)